Search Results for “EC” – Page 546 – media

Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Sale of Oncology business unlocks embedded value within Shire`s portfolio and sharpens focus on core areas reinforcing our leadership in rare diseases
- Source: finance.yahoo
- 638
- April 17, 2018
Company Insights oncology rare diseases
New blood pressure guidelines could put lives at risk, say experts

A new report in JAMA Internal Medicine by University of Sydney and Bond University scholars weighs the risks and benefits of a recent change to blood pressure guidelines in the US.
- Source: MedicalXpress
- 558
- April 17, 2018
blood pressure Policies
Telemedicine robot enables physician consultations in multiple locations

Using the device, called a Beam, Miramont Family Medicine now sees more patients than ever – enabling physicians to be in more than one of its four locations at the same time.
- Source: HealthIT News
- 542
- April 17, 2018
Company Insights mHealth Telemedicine
Sword Health lands $4.6M for digital physical therapy

Digital physiotherapy company Sword Health has brought in $4.6 million in a seed funding round led by Green Innovation, Vesalius Biocapital III, and other unnamed US and European investors.
- Source: MobiHealthNews
- 834
- April 17, 2018
AI Company Insights digital health
Pfizer Doses First Patient Using Investigational Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy

Pfizer Inc. has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate, PF-06939926, in boys with Duchenne muscular dystrophy (DMD). The first boy received an infusion of the mini-dystrophin gene on March 22nd, administered under the supervision of principal investigator, Edward Smith, MD, Associate Professor of Pediatrics and Neurology at Duke University Medical Center.
- Source: finance.yahoo
- 624
- April 16, 2018
Clinical Trials DMD
Brentuximab Vedotin Approved for Classical HL

The US Food and Drug Administration (FDA) has approved brentuximab vedotin (Adcetris) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL), in combination with chemotherapy.
- Source: cancernetwork
- 657
- April 16, 2018
ADCETRIS cHL New Approvals
GSK hands rare disease gene therapies over to Orchard

Orchard Therapeutics has snapped up GlaxoSmithKline’s portfolio of approved and investigational rare disease gene therapies. The deal sees GSK become an investor in Orchard, with a 19.9 percent equity stake along with a seat on the firm’s board. The UK drugs giant also stands to receive royalties and commercial milestone payments related to the acquired portfolio.
- Source: pharmatimes
- 660
- April 16, 2018
GSK Market Views rare disease gene therapies
RubrYc Therapeutics Completes $10M Million Series A Financing

RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Venture Capital.
- Source: prnewswire
- 914
- April 16, 2018
antibody biotherapeutics Series
Oxygen device maker Inogen discloses customer data breach

Oxygen supply device maker Inogen Inc said on Friday it was notifying 30,000 existing and former customers following a data breach that led to improper access of personal details of some rental clients.
- Source: Reuters
- 487
- April 16, 2018
Company Insights cybersecurity EHR
50 percent of EHR-using docs unsatisfied with patient data access

A recent survey of 300 primary care physicians who use EHRs found that half of the respondents wanted better access to patient data.
- Source: MobiHealthNews
- 611
- April 16, 2018
digital health EHR Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.